AA-Levocarb CR · DIN 02245211 · 200 mg & 50 mg · CR tablet
Limited Use, Reason for Use code 64, 65 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 64, 65 required
Write on scriptone applicable Reason for Use code, 64 or 65 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 64, 65
Reason for Use code 64
For patients with Parkinson's disease who have been treated with conventional therapy (Prolopa or conventional Sinemet), and experienced adverse effects related to drug level fluctuations, such as ON/OFF or wearing off phenomena.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 65
For patients presently requiring anti-parkinsonian drug administration (levodopa/carbidopa) more than three times daily.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
AA-Levocarb CR · DIN 02245211
Manufacturer: A A Pharma Inc.; listing date 2004-07-20
Health Canada: Marketed since 2020-06-12 · brand AA-LEVOCARB CR · ATC N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR · form Tablet (extended-release) · route Oral · ingredients LEVODOPA 200 MG, CARBIDOPA 50 MG · company Aa pharma inc · schedule Prescription
AA-Levocarb CR: Formulary list price $1.43 per unit (the source does not state the unit; exact figure $1.4282). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245211)
Source record
DIN 02245211: AA-Levocarb CR
Raw flags: sec12=Y, sec3=Y
Item: 920000217; group id 931; item number 2220; lccId 00130; manufacturer id AAP
Source form: CR Tab; strength: 200mg & 50mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.4282; ministry $1.4282
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245211
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69226
Interchangeable products
Sinemet CR · DIN 00870935 · not recorded
Shortage status: not checked (no credentials)